Fetal blood flow and genetic mutations in conotruncal congenital heart disease

Laura A. Dyer, Sandra Rugonyi

Research output: Contribution to journalReview articlepeer-review

Abstract

In congenital heart disease, the presence of structural defects affects blood flow in the heart and circulation. However, because the fetal circulation bypasses the lungs, fetuses with cyanotic heart defects can survive in utero but need prompt intervention to survive after birth. Tetralogy of Fallot and persistent truncus arteriosus are two of the most significant conotruncal heart defects. In both defects, blood access to the lungs is restricted or non-existent, and babies with these critical conditions need intervention right after birth. While there are known genetic mutations that lead to these critical heart defects, early perturbations in blood flow can independently lead to critical heart defects. In this paper, we start by comparing the fetal circulation with the neonatal and adult circulation, and reviewing how altered fetal blood flow can be used as a diagnostic tool to plan interventions. We then look at known factors that lead to tetralogy of Fallot and persistent truncus arteriosus: namely early perturbations in blood flow and mutations within VEGF-related pathways. The interplay between physical and genetic factors means that any one alteration can cause significant disruptions during development and underscore our need to better understand the effects of both blood flow and flow-responsive genes.

Original languageEnglish (US)
Article number90
JournalJournal of Cardiovascular Development and Disease
Volume8
Issue number8
DOIs
StatePublished - Aug 2021

Keywords

  • Cardiac malformations
  • Cardiac neural crest cells
  • Flow-induced heart defects
  • Hemodynamics
  • Outflow tract
  • Semaphorin signaling
  • VEGF

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Fetal blood flow and genetic mutations in conotruncal congenital heart disease'. Together they form a unique fingerprint.

Cite this